Mesalamine Tablet, Delayed Release
Product Images NDC 54092-100

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 54092-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mesalamine 01)

FDA Label Image

Principal Display Panel (1.2 g Tablet Bottle Label)

Principal Display Panel (1.2 g Tablet Bottle Label)
This is a description for a medication called Mesalamine delayed-release tablets, with 1.2g per tablet and sold in a bottle containing 120 tablets. The product is manufactured by Takeda Pharmaceuticals America and is copyrighted. The output also includes some unrecognizable characters.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.